Small Airways Disease in Asthma

By  

Current Respiratory Medicine Reviews, Vol. 2, Iss. 3, 2006-08 ,pp. : 279-283

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of the Endothelin-1 Receptor Antagonist, Bosentan, on Patients with Poorly Controlled Asthma: A 17-week, Double-Blind, Placebo-Controlled Crossover Pilot Study

By Coyle Timothy B.   Metersky Mark L.  

Journal of Asthma, Vol. 50, Iss. 4, 2013-05 ,pp. : 433-437

Informa Healthcare

Access to resources Recommend Favorite

Validity of Measurement of Two Specific Biomarkers for the Assessment of Small Airways Inflammation in Asthma

By Kanazawa Hiroshi   Kyoh Shigenori   Asai Kazuhisa   Hirata Kazuto  

Journal of Asthma, Vol. 47, Iss. 4, 2010-05 ,pp. : 400-406

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

By Pearlman David   Peden David   Condemi John   Weinstein Steven   White Martha   Baitinger Leslie   Scott Catherine   Ho Shu   House Karen   Dorinsky Paul  

Journal of Asthma, Vol. 41, Iss. 8, 2004-01 ,pp. : 797-806

Informa Healthcare

Access to resources Recommend Favorite

Fluticasone Propionate HFA-134a Pressurized Metered-Dose Inhaler in Adolescents and Adults with Moderate to Severe Asthma

By Pinnas Jacob   Noonan Michael   Weinstein Steven   Chervinsky Paul   Scott Catherine   Herje Nancy   Wu Wei   Crim Courtney  

Journal of Asthma, Vol. 42, Iss. 10, 2005-12 ,pp. : 865-871

Informa Healthcare

Access to resources Recommend Favorite